Statements (75)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Biotechnology company
|
| gptkbp:accreditation |
CLIA_certified
|
| gptkbp:acquisition |
gptkb:ArcherDX
2021 |
| gptkbp:awards |
Various industry awards
|
| gptkbp:businessModel |
Direct-to-consumer and healthcare provider.
|
| gptkbp:CEO |
gptkb:Sean_George
|
| gptkbp:clinicalTrials |
Ongoing
Conducts studies on genetic conditions. Contributes to genetic testing guidelines. Improves patient care. Integrates with healthcare systems. |
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:community |
Aims to transform healthcare.
|
| gptkbp:community_service |
Genetic counseling
Affordable testing options. Works with hospitals. |
| gptkbp:communityEngagement |
Patient advocacy groups
|
| gptkbp:communityOutreach |
Educational programs.
|
| gptkbp:communityPartnerships |
Engages with local organizations.
|
| gptkbp:corporateSocialResponsibility |
Engages in community initiatives.
|
| gptkbp:customerBase |
Healthcare_providers
|
| gptkbp:customerFeedback |
Incorporates into services.
|
| gptkbp:expansion |
International markets
|
| gptkbp:financials |
Publicly traded
|
| gptkbp:focus |
Genetic diagnostics
|
| gptkbp:founded |
2010
|
| gptkbp:founder |
gptkb:Sean_George
|
| gptkbp:futurePlans |
Expand test offerings.
Leading in genetic health. |
| gptkbp:geneticDiversity |
Available for patients.
Comprehensive offerings. Rapidly growing. |
| gptkbp:hasCapacity |
Offers resources for patients.
|
| gptkbp:hasPrograms |
Composed of leading experts.
|
| gptkbp:headCoach |
gptkb:Dr._Robert_Nussbaum
|
| gptkbp:headquarters |
gptkb:California
gptkb:San_Francisco,_California |
| gptkbp:healthcare |
Strong data protection policies.
Pioneering new solutions. Resources for understanding genetic tests. |
| gptkbp:historicalResearch |
Focus on genetic disorders.
|
| https://www.w3.org/2000/01/rdf-schema#label |
Invitae Corporation
|
| gptkbp:industry |
Genetic testing
|
| gptkbp:innovation |
Genetic testing technology
|
| gptkbp:investmentFocus |
Various venture capital firms
|
| gptkbp:leadership |
Diverse executive team
|
| gptkbp:localEconomy |
Improving health outcomes.
|
| gptkbp:market |
Global
Leader in genetic testing. Staying ahead in genetics. |
| gptkbp:marketingStrategy |
Focus on innovation.
|
| gptkbp:mission |
To bring comprehensive genetic information into mainstream medicine.
|
| gptkbp:missions |
To make genetic information accessible.
|
| gptkbp:numberOfEmployees |
Over 1,000
|
| gptkbp:partnerships |
Pharmaceutical companies
Various healthcare organizations Open for collaborations. |
| gptkbp:products |
Genetic tests
|
| gptkbp:publications |
Research articles in genetics.
|
| gptkbp:regulatoryCompliance |
Meets industry standards.
FDA_approved_tests |
| gptkbp:researchFocus |
Rare diseases
|
| gptkbp:researchInterest |
With leading universities.
|
| gptkbp:revenue |
$200 million (2020)
|
| gptkbp:services |
Genetic information
|
| gptkbp:stockSymbol |
gptkb:NVTA
|
| gptkbp:strategicGoals |
Expand genetic testing access.
|
| gptkbp:subsidiary |
GeneDx
|
| gptkbp:technology |
Next-generation sequencing
Invests in R&D. Cloud-based data management. |
| gptkbp:type |
Public company
Compliant with HIPAA |
| gptkbp:website |
www.invitae.com
|